NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Consulting Services · USD

SBC Medical Group Holdings Incorporated (SBC) Stock Analysis

SBC Medical Group Holdings Incorporated (SBC) is a Consulting Services stock listed on NASDAQ and quoted in US Dollar.

SBC

$4.12

−$0.16 (−3.74%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare SBC with… →

SBC Key Statistics

As of Sep 4, 2026
Trading
Open
$4.25
Previous Close
$4.28
Day's Range
4.06–4.25
52-Week Range
2.78–5.07
Volume
141.00K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.63
Valuation
Market Cap
$423.73M
P/E Ratio
8.96
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
7.63
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.64
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.42
EPS (ttm)Profit attributable to each share over the last twelve months.
0.46
Financials (FY)
Revenue (FY)
$173.61M−15.48%
Net Income (FY)
$50.99M+9.38%
Profit marginThe share of revenue left as profit after all costs and taxes.
27.99%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
102.85M
1-Year Return
+1.23%
Dividend and dates
Earnings Date
November 12, 2026
Avg Volume
137.49K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

SBC Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−4.41%
2025−22.48%
2024−48.38%
2023+5.59%
2022 (partial year)+2.41%

As of September 4, 2026.

SBC Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$173.61M$50.99M29.4%
2024$205.42M$46.61M22.7%
2023$193.54M$39.37M20.3%
2022$174.16M$6.32M3.6%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$173.61M$127.28M$67.49M$50.99M29.4%
2024$205.42M$156.05M$85.36M$46.61M22.7%
2023$193.54M$137.30M$71.07M$39.37M20.3%
2022$174.16M$114.83M$21.35M$6.32M3.6%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

SBC Valuation vs Consulting Services Median

Median of 23 stocks
MetricSBCConsulting Services medianvs median
P/E8.9620.6857% below
P/S ratio2.422.420% above
Profit margin27.99%1.28%26.7 pts above

Medians across 23 Consulting Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 8 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values SBC Medical Group Holdings Incorporated (SBC) at $423.73M. The company sits in the Industrials sector, in the Consulting Services industry. Headcount on file is 863.

SBC last closed at $4.12 on September 4, 2026. That is −$0.16 (−3.74%) against the previous close. Over the past 52 weeks the price has ranged from $2.78 to $5.07. The latest close sits 48.2% above that 52-week low.

Financial Health

In fiscal 2025, SBC Medical Group Holdings Incorporated reported revenue of $173.61M. Against the prior fiscal year total of $205.42M, that is a change of −15.48%. Net income for the same year was $50.99M. That is +9.38% against the prior fiscal year. Profit margin runs at 27.99%. That is 26.7 percentage points above the Consulting Services median of 1.28%. Trailing earnings per share are 0.46.

Across the 4 fiscal years on file, revenue moves from $174.16M in 2022 to $173.61M in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

SBC trades at a trailing price-to-earnings ratio of 8.96. That is 56.67% below the Consulting Services median of 20.68. The forward P/E on file is 7.63. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.64. The price-to-sales ratio is 2.42. On price-to-sales that is 0% above the Consulting Services median of 2.42. The medians here are taken across 23 Consulting Services companies that report the metric.

The trailing one-year price return is +1.23%. Measured over 3 years, that is −27.04% a year compounded. Beta against the wider market is reported at 0.63. Daily returns over the trailing 3 years annualize to a volatility of 76.09%.

Growth & Income

The record shows no dividend for SBC.

Across the complete calendar years on file, 2023 returned +5.59% and 2024 returned −48.38%. Of the 3 complete calendar years on file, 1 finished higher. 2026 is still running; the price is −4.41% year to date.

Peer Comparison

SBC Medical Group Holdings Incorporated (SBC) operates in the Consulting Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
SBC Medical Group Holdings Incorporated SBC $423.73M 9.0
Verisk Analytics, Inc. VRSK $24.18B 28.5
Equifax Inc. EFX $20.80B 33.2
Booz Allen Hamilton Holding Corporation BAH $8.76B 11.4

The Consulting Services industry average P/E ratio is 20.7x. SBC Medical Group Holdings Incorporated trades at a P/E of 9.0.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Consulting Services Stocks

VRSK

Verisk Analytics, Inc.

$24.18B

 EFX

Equifax Inc.

$20.80B

 BAH

Booz Allen Hamilton Holding Corporation

$8.76B

 FCN

FTI Consulting, Inc.

$4.19B

 HURN

Huron Consulting Group Inc.

$2.47B

 ICFI

ICF International, Inc.

$1.58B
View all Consulting Services stocks →

Popular Industrials Stocks

SPCX

Space Exploration Technologies Corp.

$1.95T

 CAT

Caterpillar Inc.

$374.15B

 GE

GE Aerospace

$349.78B

 RTX

RTX Corporation

$270.62B

 GEV

GE Vernova Inc.

$250.87B
View all Industrials stocks →

About SBC Medical Group Holdings Incorporated

SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement. It also provides loyalty program management, labor and function supporting, and management consulting services; and IT software solutions, as well as engages in franchising activities; and distributes medical equipment and devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale to clinic customers. In addition, the company offers surgical and non-surgical surgeries that include breast augmentation; liposuction; rejuvenation treatments, such as treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. Further, it owns and operates treatment centers under the SBC brand. SBC Medical Group Holdings Incorporated was founded in 2000 and is headquartered in Irvine, California.

Visit website →